Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu

Why Obesity Is a Chronic Disease (Not a Failure of Willpower)—featuring Isabelle

42% of adults in the US qualify as obese. But there are only a few thousand doctors board-certified in obesity, most of whom work exclusively in academic medical centers.  So, what can we do to address the obesity epidemic in our country? How do we give the 200 million Americans struggling with metabolic health access to the information and support they need? Isabelle Kenyon is Founder and CEO of <a href="https://www.joincalibrate.com/pages/hello" target="_blank">Calibrate</a>, a metabolic health company on a mission to change the way the world treats weight. In two years, Calibrate has raised more than $125 million and published clinically-reviewed results from its One-Year Metabolic Reset that exceeded the best outcomes from clinical trials across all metabolic markers. On this episode of HLTH Matters, Isabelle joins host Dr. Jessica Shepherd to explain how Calibrate partners medication and lifestyle interventions to promote long-term weight loss. Isabelle discusses the biggest contributors to sustained success with Calibrate, describing how the program helps members improve their metabolic health. Listen in for Isabelle’s insight on treating obesity like a chronic disease (not a failure of willpower) and learn how Calibrate tailors its program to your biology, your goals and your life for sustained weight loss—guaranteed. Topics Covered<ul><li>How her mom’s struggle with weight inspired Isabelle to build Calibrate</li><li>The 4 pillars of metabolic balance Calibrate uses to instill lifestyle change</li><li>How metabolic health sets us up for long-term, sustained weight loss</li><li>What it looks like to work through the Calibrate program</li><li>Why Calibrate partners medication with lifestyle interventions</li><li>How Isabelle thinks about educating consumers on metabolic health</li><li>Why Calibrate is designed to prove sustained results after medication</li><li>How engagement and community contribute to sustained success with Calibrate</li><li>How Calibrate sets expectations with clients and guarantees results</li><li>Treating obesity like the chronic disease it is vs. a failure of willpower</li></ul> Connect with Isabelle Kenyon<a href="https://www.joincalibrate.com/pages/hello" target="_blank">Calibrate</a> Connect with Dr. Jessica Shepherd<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/JShepherd_MD" target="_blank">Dr. Shepherd on Twitter</a><a href="https://www.linkedin.com/in/jessica-shepherd-md-mba-5ba9ab66/" target="_blank">Dr. Shepherd on LinkedIn</a> Resources<a href="https://www.cdc.gov/diabetes/prevention/index.html" target="_blank">National Diabetes Prevention Program</a><a href="https://www.cdc.gov/pcd/issues/2017/16_0287.htm" target="_blank">The CDC Definition of Metabolic Health</a>

S3 Ep28: Why Obesity Is a Chronic Disease (Not a Failure of Willpower)—featuring Isabelle Kenyon

Founder & CEO

Partnerships + Prevention = Value-Driven Care — featuring Katie Adamson of YMCA

S1 Ep3: Partnerships + Prevention = Value-Driven Care — featuring Katie Adamson of YMCA of the USA

Vice President, Health Partnerships and Policy

Solving for the Disparity in Cancer Outcomes—featuring Feyi Olopade Ayodele

For most cancers, Black Americans have the highest death rate and shortest survival of any patient population. And access to genetic testing is key to eliminating this disparity. Feyi Olopade Ayodele is Cofounder and CEO of <a href="https://www.canceriq.com/" target="_blank">CancerIQ</a>, a company on a bold mission to end cancer as we know it by giving providers and health systems access to the latest innovations in early cancer detection and prevention. Under Feyi’s leadership, <a href="https://www.canceriq.com/" target="_blank">CancerIQ</a> has grown its provider network to over 200 locations across the US and established a robust ecosystem of leading diagnostic and genomic testing vendors. On this episode of HLTH Matters, Feyi joins host Dr. Jessica Shepherd to explain how she built CancerIQ to solve for the disparity in access to genetic testing by making it part of everyone’s primary care visit. Feyi describes how CancerIQ helps patients initiate conversations around cancer prevention with their providers and gives providers the right precision prevention program for each patient.  Listen in for Feyi’s insight on the emotional journey associated with a cancer diagnosis and learn how CancerIQ is helping African American and rural patient populations prevent cancer or detect it in its earliest stages. Topics Covered<ul><li>Disparities in breast cancer outcomes between Black women and other patient populations</li><li>Why Feyi built CancerIQ to solve for the disparity in access to genetic testing</li><li>How CancerIQ makes it easy for providers to navigate patients to the right precision cancer prevention program</li><li>Why Feyi encourages primary genetic care vs. specialty genetic care</li><li>How CancerIQ helps patients initiate conversations on cancer prevention with their providers</li><li>How CancerIQ is closing the gap for African American and rural patient populations</li><li>What CancerIQ does to help patients adhere to a cancer prevention plan</li><li>How CancerIQ recognizes the emotional journey associated with a cancer diagnosis</li><li>Feyi’s vision to make CancerIQ part of everyone’s preventative care visit and detect cancer in its earliest stages</li></ul>   Connect with Feyi Olopade Ayodele<a href="https://www.canceriq.com/" target="_blank">CancerIQ</a>  Connect with Dr. Jessica Shepherd<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/JShepherd_MD" target="_blank">Dr. Shepherd on Twitter</a><a href="https://www.linkedin.com/in/jessica-shepherd-md-mba-5ba9ab66/" target="_blank">Dr. Shepherd on LinkedIn</a>  Resources<a href="https://www.nccn.org/guidelines/category_1" target="_blank">NCCN Guidelines</a><a href="https://open.spotify.com/show/18JVSlByKE0tVPRkYumWgJ" target="_blank">Small Talk Baby Podcast</a>

S3 Ep30: Solving for the Disparity in Cancer Outcomes—featuring Feyi Olopade Ayodele

Co-Founder & CEO

The Heart of Pharma: Building Connections for Effective Marketing

Marketing can play a huge role in improving health outcomes. In this episode, Craig Douglass, Chief Growth Officer at Digitas Health, discusses his focus on integrating creativity, media, and technology in healthcare communications. He highlights the opportunity to use marketing for good, emphasizing the positive impact of engaged healthcare consumers on outcomes. Craig delves into the challenges pharmaceutical brands face, highlighting the need for responsiveness and overcoming fragmentation. He also urges pharmaceutical marketers to focus on making connections within their marketing systems.  Tune in and learn how to navigate the evolving landscape of healthcare marketing to drive better outcomes! About Craig Douglass:Craig Douglass holds the role of Chief Growth Officer at Digitas Health, a leading global agency specializing in connected health. With more than 25 years in the field, he&#39;s developed expertise in crafting impactful campaigns and content that improve health results in various areas like cancer, respiratory issues, diabetes, vaccines, immunology, infectious disease, and mental health. His commitment to blending creativity, media, and technology has placed him at the forefront of the healthcare communications industry&#39;s digital transformation. Working at Digitas Health, the pioneering connected-health agency, Douglass helps health brands navigate the complexities of an ever-changing media landscape. Things You’ll Learn:<ul><li>Marketing plays a crucial role in improving health outcomes.</li><li>Better engagement in healthcare leads to improved results for individuals.</li><li>The ever-changing landscape demands responsiveness over speed and adaptation to new circumstances.</li><li>The heart of pharmaceutical marketing lies in the connection between physicians and patients.</li><li>Rather than seeking an omnichannel agency, prioritize finding one that can effectively build your brand and drive results across multiple channels.</li><li>Simplicity is essential, and distinguishing the signal from the noise is crucial to effective marketing.</li></ul> Resources:<ul><li>Connect with and follow Craig Douglass on <a href="https://www.linkedin.com/in/craig-douglass-3710641/" target="_blank">LinkedIn</a>.</li><li>Follow Digitas Health on <a href="https://www.linkedin.com/company/digitas-health/" target="_blank">LinkedIn</a>.</li><li>Visit Digitas Health on their <a href="https://www.digitashealth.com/" target="_blank">Website</a>.</li></ul>

S4 E16: The Heart of Pharma: Building Connections for Effective Marketing

Chief Growth Officer

Podcast

S3 Ep28: Why Obesity Is a Chronic Disease (Not a Failure of Willpower)—featuring Isabelle Kenyon

FEATURING